. NONO is a poor prognostic factor for breast cancer patients. Figure S2. NONO associates breast cancer cell proliferation.
. NONO is a poor prognostic factor for breast cancer patients. Figure S8 . SKP2 and E2F8 are poor prognostic factor for ER-positive breast cancer patients. Table S1 . Sequences of siRNAs used in the present study. Table S2 . Primers used in the present study. Table S3 . Association between NONO status and clinicopathological parameters in 127 human breast cancer patients. Figure S2 . NONO associates breast cancer cell proliferation. A, B, 3-(4,5-dimethylthiazol-2-yl)-2,5-disphenyltetrazolium bromide, yellow tetrazole (MTT) cell proliferation assay was performed at the indicated time points after the siRNA transfection in MCF-7 (A) and MDA-MB-231 (B) cells. The absorbance of the plates was read on a microplate reader at 492 nm. Results are shown as mean ± SD (n = 5). ***, P < 0.001. 
